Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Psychosis TMS Study

NCT: NCT05857137 · ACTIVE_NOT_RECRUITING

NCT IDNCT05857137
StatusACTIVE_NOT_RECRUITING
Start Date2023-04-04
Completion2027-06-30
SponsorMassachusetts General Hospital (OTHER)
First posted
Last updated

Brief Summary

The main goal of this study is to investigate the neural mechanisms of working memory function in patients with early psychosis using Transcranial Magnetic Stimulation (TMS) in conjunction with functional MRI. TMS is a noninvasive method used to modulate brain activity via changing magnetic fields applied over the surface of the scalp.

Frequently Asked Questions

What is Psychosis TMS Study?

Psychosis TMS Study is a clinical trial registered under NCT05857137. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05857137?

The current status of NCT05857137 (Psychosis TMS Study) is: ACTIVE_NOT_RECRUITING.

When did Psychosis TMS Study start?

Psychosis TMS Study started on 2023-04-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.